These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 12508362)

  • 1. HBV DNA vaccine with adjuvant cytokines induced specific immune responses against HBV infection.
    Du DW; Jia ZS; Li GY; Zhou YY
    World J Gastroenterol; 2003 Jan; 9(1):108-11. PubMed ID: 12508362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineering enhancement of the immune response to HBV DNA vaccine in mice by the use of LIGHT gene adjuvant.
    Zhang Y; Jiang W; Fan Y; Wen J; Hao W; Qian M
    J Virol Methods; 2008 Nov; 153(2):142-8. PubMed ID: 18722475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement of hepatitis B virus DNA vaccines by plasmids coexpressing hepatitis B surface antigen and interleukin-2.
    Chow YH; Huang WL; Chi WK; Chu YD; Tao MH
    J Virol; 1997 Jan; 71(1):169-78. PubMed ID: 8985336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Enhancement of immune responses to hepatitis B DNA vaccine by superantigen SEA in mice].
    Jin YW; Li P; Xu QB; Liu X; Huang W; Wang YL; Cao C; Ma QJ
    Sheng Wu Gong Cheng Xue Bao; 2005 Sep; 21(5):681-5. PubMed ID: 16285504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracellular retention of hepatitis B virus surface proteins reduces interleukin-2 augmentation after genetic immunizations.
    Geissler M; Bruss V; Michalak S; Hockenjos B; Ortmann D; Offensperger WB; Wands JR; Blum HE
    J Virol; 1999 May; 73(5):4284-92. PubMed ID: 10196326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cloning, protein expression and immunogenicity of HBs-murine IL-18 fusion DNA vaccine.
    Channarong S; Mitrevej A; Sinchaipanid N; Usuwantim K; Kulkeaw K; Chaicumpa W
    Asian Pac J Allergy Immunol; 2007 Dec; 25(4):233-42. PubMed ID: 18402297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of hepatitis C virus-specific cytotoxic T and B cell responses by dendritic cells expressing a modified antigen targeting receptor.
    Wang QC; Feng ZH; Zhou YX; Nie QH
    World J Gastroenterol; 2005 Jan; 11(4):557-60. PubMed ID: 15641145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A truncated C-terminal fragment of Mycobacterium tuberculosis HSP70 gene enhanced potency of HBV DNA vaccine.
    Li X; Yang X; Li L; Liu H; Liu J
    Vaccine; 2006 Apr; 24(16):3321-31. PubMed ID: 16472546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination with a fusion DNA vaccine encoding hepatitis B surface antigen fused to the extracellular domain of CTLA4 enhances HBV-specific immune responses in mice: implication of its potential use as a therapeutic vaccine.
    Zhou C; Peng G; Jin X; Tang J; Chen Z
    Clin Immunol; 2010 Nov; 137(2):190-8. PubMed ID: 20692873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel dendritic-cell-targeting DNA vaccine for hepatitis B induces T cell and humoral immune responses and potentiates the antivirus activity in HBV transgenic mice.
    Yu D; Liu H; Shi S; Dong L; Wang H; Wu N; Gao H; Cheng Z; Zheng Q; Cai J; Zou L; Zou Z
    Immunol Lett; 2015 Dec; 168(2):293-9. PubMed ID: 26475398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nasal route favors the induction of CD4
    Bourgine M; Crabe S; Lobaina Y; Guillen G; Aguilar JC; Michel ML
    Antiviral Res; 2018 May; 153():23-32. PubMed ID: 29510155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poly(I:C)/alum mixed adjuvant priming enhances HBV subunit vaccine-induced immunity in mice when combined with recombinant adenoviral-based HBV vaccine boosting.
    Chuai X; Chen H; Wang W; Deng Y; Wen B; Ruan L; Tan W
    PLoS One; 2013; 8(1):e54126. PubMed ID: 23335993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A fusion DNA vaccine encoding middle version of HBV envelope protein fused to interleukin-21 did not enhance HBV-specific immune response in mice.
    Zhang Y; Su WJ; Wang J; Bai XF; Huang CX; Lian JQ
    Viral Immunol; 2014 Nov; 27(9):430-7. PubMed ID: 25211639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Priming MHC-I-restricted cytotoxic T lymphocyte responses to exogenous hepatitis B surface antigen is CD4+ T cell dependent.
    Wild J; Grusby MJ; Schirmbeck R; Reimann J
    J Immunol; 1999 Aug; 163(4):1880-7. PubMed ID: 10438922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of interleukin-12 on HBV pan-S gene vaccine].
    Tan DM; Yang YF; Liu SP
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Feb; 29(1):47-9. PubMed ID: 16137004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Suppression of the antigen-specific T cell immune response by co-immunization with the HBV DNA vaccine and recombinant HBsAg].
    Du X; Wang J; Kang Y; Xiao W; Zhao G; Wang B
    Wei Sheng Wu Xue Bao; 2009 Jul; 49(7):938-42. PubMed ID: 19873759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lentiviral vector encoding ubiquitinated hepatitis B core antigen induces potent cellular immune responses and therapeutic immunity in HBV transgenic mice.
    Dai S; Zhuo M; Song L; Chen X; Yu Y; Zang G; Tang Z
    Immunobiology; 2016 Jul; 221(7):813-21. PubMed ID: 26874581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism and therapeutic potential of DNA-based immunization against the envelope proteins of hepatitis B virus in normal and transgenic mice.
    Oka Y; Akbar SM; Horiike N; Joko K; Onji M
    Immunology; 2001 May; 103(1):90-7. PubMed ID: 11380696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-12-based vaccination therapy reverses liver-induced systemic tolerance in a mouse model of hepatitis B virus carrier.
    Zeng Z; Kong X; Li F; Wei H; Sun R; Tian Z
    J Immunol; 2013 Oct; 191(8):4184-93. PubMed ID: 24048897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Localization of CD8+ cells specific for hepatitis B virus surface protein in the liver of immunized mice.
    Qu D; Lanier G; Yuan ZH; Wen YM; Howard CR; Ahmed R
    J Med Virol; 2008 Feb; 80(2):225-32. PubMed ID: 18098130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.